Search results
Allergan Aesthetics develops, manufactures, and markets a portfolio of leading brands and products including facial injectables, body contouring, plastics, skin care, and more.
Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
Advantage is your online destination to access your favorite Allergan Aesthetics programs, product information, marketing materials, training resources and more.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970.
Allergan is now part of AbbVie. Together, we are dedicating more to R&D to drive tomorrow’s breakthroughs, while helping people live better lives today. With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio.
May 8, 2020 · Allergan provides new growth opportunities in Neuroscience, with Botox® Therapeutics, Vraylar® and Ubrelvy ™ and a global aesthetics business, with leading brands including Botox® and Juvederm®.
Nov 30, 2022 · That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, stronger and more diversified global biopharmaceutical company. It was an acquisition that allowed us to grow in numbers and bolster our ability to improve people’s lives worldwide.
Nov 23, 2015 · Here's the story of how Allergan went from a small Los Angeles company known for making eye-drops to an Ireland-domiciled drug giant to 2015's biggest takeover target.
Allergan is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.
